Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSGALNACT1 | Q8TDX6 | 20/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2294312 | 1.00 | CSGALNACT1 (0.74) | CSGALNACT1 | |
| SCHEMBL2294473 | 0.94 | CSGALNACT1 (0.73) | CSGALNACT1 | |
| SCHEMBL2294475 | 0.94 | CSGALNACT1 (0.73) | CSGALNACT1 | |
| SCHEMBL2297732 | 0.92 | CSGALNACT1 (0.88) | CSGALNACT1 | |
| SCHEMBL2297726 | 0.92 | CSGALNACT1 (0.88) | CSGALNACT1 | |
| SCHEMBL2293688 | 0.92 | CSGALNACT1 (0.78) | CSGALNACT1 | |
| SCHEMBL2293684 | 0.92 | CSGALNACT1 (0.78) | CSGALNACT1 | |
| SCHEMBL2294315 | 0.91 | CSGALNACT1 (0.69) | CSGALNACT1 | |
| SCHEMBL2296640 | 0.89 | CSGALNACT1 (0.68) | CSGALNACT1 | |
| SCHEMBL2296638 | 0.89 | CSGALNACT1 (0.68) | CSGALNACT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110196002-A1 | DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS | PIRAMAL LIFE SCIENCES LIMITED. | 2011-08-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110196002-A1 | DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS | DGAT1, DGAT2, DLAT | CSGALNACT1 455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.